Prescription Patterns, Resource Utilization & Costs - Add-on Therapy With Anti Dipeptidyl Peptidase-IVs vs Rosiglitazone

CompletedOBSERVATIONAL

Enrollment

5,391

Participants

Timeline

Start Date

December 31, 2009

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Rosiglitazone + Metformin

At least 180 days of continuous therapy with RSG+MET after the first Rx for RSG

DRUG

Sitagliptin + Metformin

At least 180 days of continuous therapy with STG+MET after the first Rx for STG